Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000932471-25-000756·ARROWHEAD PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
ARROWHEAD PHARMACEUTICALS INC COM
Common Stock · CUSIP: 04280A100
Event date: 2025-06-30
- Filing-level shares
- 15,525,072
- Percent of class
- 11.24%
- The Vanguard Group
Shares: 15,525,072 · Class: 11.24%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000756
- Form type
- SCHEDULE 13G/A
- Filer
- ARROWHEAD PHARMACEUTICALS, INC.
- CIK
- CIK 879407
- Filed
- Jul 29, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership